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Neuregulin 1 (NRG1) is a growth factor involved in neurodevelop-
ment and plasticity. It is a schizophrenia candidate gene, and
hippocampal expression of the NRG1 type I isoform is increased in
the disorder. We have studied transgenic mice overexpressing
NRG1 type I (NRG1
tg-type I) and their wild-type littermates and
measured hippocampal electrophysiological and behavioral pheno-
types. Young NRG1
tg-type I mice showed normal memory perfor-
mance, but in older NRG1
tg-type I mice, hippocampus-dependent
spatial working memory was selectively impaired. Hippocampal
slice preparations from NRG1
tg-type I mice exhibited a reduced
frequency of carbachol-induced gamma oscillations and an in-
creased tendency to epileptiform activity. Long-term potentiation in
NRG1
tg-type I mice was normal. The results provide evidence that
NRG1 type I impacts on hippocampal function and circuitry. The
effects are likely mediated via inhibitory interneurons and may be
relevant to the involvement of NRG1 in schizophrenia. However, the
ﬁndings, in concert with those from other genetic and pharmaco-
logical manipulations of NRG1, emphasize the complex and
pleiotropic nature of the gene, even with regard to a single isoform.
Keywords: gamma oscillation, hippocampus, neuregulin, schizophrenia,
synaptic plasticity
Introduction
Neuregulin 1 (NRG1) is a member of the epidermal growth factor
family. It signals through ErbB2--4 receptors and has diverse roles
in development and plasticity (Buonanno and Fischbach 2001;
Corfas et al. 2004; Rico and Marin 2011). Its pleiotropy reﬂects, in
part, the generation of multiple isoforms, notably those resulting
from alternative 5# exons, called ‘‘types.’’ Classically, types I--III are
recognized (Falls 2003), although types IV--VI have recently been
identiﬁed (see Mei and Xiong 2008). Isoform-speciﬁc distribu-
tions, roles, and properties have been described, although they
remain incompletely understood (Meyer et al. 1997; Flames et al.
2004; Michailov et al. 2004; Taveggia et al. 2005; Tan et al. 2007;
Brinkmann et al. 2008; Chen et al. 2008).
Many studies of NRG1 have concentrated on early neuro-
developmental processes such as cell differentiation, synapto-
genesis, and myelination, and studies initially focused on the
peripheral rather than the central nervous system (CNS).
However, NRG1 is also expressed throughout adulthood (Kerber
et al. 2003; Law et al. 2004), and recent studies, discussed below,
provide compelling evidence for its functionality in brain (for
review, see Mei and Xiong 2008). A major psychiatric relevance
of NRG1 emerges because its locus is implicated in neuro-
developmental disorders (Tabares-Seisdedos and Rubenstein
2009) and, in particular, from evidence that NRG1 is a schizo-
phrenia susceptibility gene, in its own right (Stefansson et al.
2002; Li et al. 2006; Keri et al. 2009) and in epistasis with other
genes in the NRG1 signaling pathway (Nicodemus et al. 2010).
The expression and function of NRG1 is altered in schizophrenia
and in people carrying NRG1 risk alleles (Hahn et al. 2006; Hall
et al. 2006; Harrison and Law 2006; Chen et al. 2009; Nicodemus
et al. 2009); notably, there is an isoform-speciﬁc increase in type
I NRG1 messenger RNA in the disorder (Hashimoto et al. 2004;
Law et al. 2006).
The genetic associations with schizophrenia have encour-
aged more studies of NRG1 in the adult CNS, including analysis
of various heterozygous NRG1 knockout mice. The results
show diverse functional effects, including ‘‘schizophrenia-like’’
behavioral and other phenotypes (Stefansson et al. 2002; Rimer
et al. 2005; Karl et al. 2007; O’Tuathaigh et al. 2007; Chen et al.
2008; Ehrlichman et al. 2009; Duffy et al. 2010; Nason et al. 2011).
However, very little is known about the consequences of
genetically enhanced NRG1 signaling, nor the speciﬁc effects of
the type I isoform, both of which might be of greater relevance to
schizophrenia than are hypomorphs. Transgenic mice selectively
overexpressing NRG1 type I (‘‘NRG1
tg-type I mice’’) have been
created primarily to study peripheral myelination (Michailov et al.
2004; Brinkmann et al. 2008). Analysis of their behavior is limited
to an initial screen of ~4-month-old mice, which revealed an
increased startle response, impaired prepulse inhibition, a tran-
sient locomotor hypoactivity when ﬁrst placed into activity cages,
and no signiﬁcant anxiety phenotype (Deakin et al. 2009). The
mice also have a tremor, likely related to aberrant myelination
(Michailov et al. 2004), which results in decreased performance
on some motor tasks (Deakin et al. 2009).
Here, to help understand the consequences of overexpres-
sion of type I NRG1 for higher cognitive function, we report
a detailed behavioral and electrophysiological characterization
of NRG1
tg-type I mice. We focused on the hippocampus, given
its importance in cognition (Morris 2006) and schizophrenia
(Harrison 2004), and since this is the region wherein type I NRG1
overexpression in the disorder was most clearly demonstrated
(Law et al. 2006).
Materials and Methods
All experiments were conducted in accordance with the UK Animals
(Scientiﬁc Procedures) Act, 1986, and had local ethical approval.
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tg-type I Mice
The generation and genotyping of NRG1
tg-type I mice has been
described (Michailov et al. 2004). The mice express NRG1 type I
(b1a-isoform) under a Thy-1 promoter, with robust overexpression in
multiple brain regions (Brinkmann et al. 2008), notably the pyramidal
cell and granule cell layers of the hippocampus, deep layers of cerebral
cortex, and brain stem nuclei, but not in cerebellum or striatum
(Supplementary Fig. 1; see also Deakin et al. 2009). Expression of NRG1
types II and III isoforms is unaffected (see Supplementary Materials and
Supplementary Table 1). The experiments reported here were
performed in F6--F9 generations of backcross of heterozygous
NRG1
tg-type I males with wild-type (wt) C57BL/6J females, comparing
NRG1
tg-type I mice with their wt littermates.
Behavioral Phenotyping
Mice were group housed with same-sex littermates. A 12-h lighting
scheme was maintained (lights on 7--19 h) and testing performed with
mice from each genotype interleaved (9--17 h).
Locomotor activity was measured in transparent plastic cages (26 3
16 3 17 cm) containing a thin layer of bedding with 2 photocell beams
crossing the bottom of the cage. The number of crossovers were
recorded in a 2-h period (9--11 h). Locomotor activity was assessed in
the same cohort of mice at 5, 7.5, 10, and 12.5 months.
For spatial memory tests, mice were maintained on a food-
deprivation schedule of >85% free-feeding weight with ad libitum
access to water. Mice were ﬁrst habituated to drinking 50% condensed
milk. Working memory was assessed using spatial nonmatching-to-
place testing (rewarded alternation) in a T-maze (Deacon et al. 2002;
Deacon and Rawlins 2006). Mice were run in batches of 5--6 with an
intertrial interval of approximately 10 min and with 5 trials per day for
10 days. Short-term memory was also tested using a single-trial, spatial
novelty preference (spontaneous alternation) task, performed as
described (Sanderson et al. 2007). Spatial reference memory was
assessed on an elevated Y-maze. The tests were performed in mice at
3--5 months and 10--11 months, as described in Results. For full details
of behavioral tasks, see Supplementary Materials.
Synaptic Transmission and Long-term Potentiation in CA1
Recordings were performed in the stratum radiatum of CA1 on 400 lm
sagittal hippocampal slices from mice aged 2.5--5 months and 10--13
months, as described (Romberg et al. 2009). For details, see
Supplementary Materials. The magnitude of the ﬁeld excitatory post-
synaptic potential (fEPSP) response was measured by the slope of the
central third of the rising phase. Stimulus response curves were
investigated for stimulus strengths from 5 to 350 lA. Five repetitions of
paired 50-ls stimuli, 50 ms apart, were presented for each of the
stimulation strengths at 0.2 Hz. The mean fEPSP slope of the ﬁrst
stimulus in each pair was calculated. Paired pulse facilitation (PPF) was
calculated by the ratio of the second to the ﬁrst fEPSP slope of a stimuli
pair at a stimulation strength in the exponential phase of the stimulus
response curve.
Long-term potentiation (LTP) was induced by theta burst stimulation
(TBS), which was 10 trains of 4 pulses at 100 Hz separated by 200 ms
(Bjarnadottir et al. 2007). Stimuli were presented at 0.1 Hz at half the
strength that induced the maximal fEPSP response (50% Vmax). If the
baseline fEPSP slope was stable (<20% variation) for 15 min, TBS was
presented. The magnitude of LTP was deﬁned as the mean percent
baseline fEPSP slope 46--50 min after TBS. Data from each mouse (the
mean values from its slices) were analyzed with analysis of variance
with between-subjects factors of genotype, age, and sex.
Electrophysiology: Oscillations and Cell Recordings
Carbachol-induced gamma oscillations (Fisahn et al. 1998) were studied
using horizontal brain slices from mice aged 3--6 months (Oren et al.
2006). Rhythmic extracellular ﬁeld activity was recorded in CA3b/c
upon application of 5--20 lM carbachol (Sigma-Aldrich, UK) using an
artiﬁcial cerebrospinal ﬂuid (ACSF)-ﬁlled pipette (3--5 MX) placed at
the stratum pyramidale--oriens border. Temperature in the submerged
recording chamber was kept between 28 and 32  C to reduce
metabolic rate and enable sufﬁcient oxygenation and to display
pronounced and stable oscillatory cycles (Fisahn et al. 2009; Gulyas
et al. 2010). Firing from individual neurons was detected using a second
ACSF-ﬁlled pipette (4--8 MX) placed in the stratum pyramidale in close
proximity to the ﬁeld pipette. Currents underlying the generation of
action potentials were recorded in voltage clamp mode for ~30 to 60 s
once seal resistance had reached >500 MX as loose cell patch.
Recordings were digitally ﬁltered using a bidirectional Igor Digital
Signal Processing ﬁlter (Oren et al. 2006). Field recordings were low-
pass ﬁltered at 200 Hz, while cell-attached recordings were high-pass
ﬁltered at 1 Hz. The power of the ﬁeld oscillations was estimated by
means of power spectral density (PSD) analysis on ~30- to 60-s-long
epochs, taken at least 5 min following exposure to carbachol (see
Supplementary Fig. 2). For this, a discrete fast Fourier transform was
calculated on a sliding window of ~1.5 s with consecutive sliding
windows overlapping by 50%. The windows were multiplied by
a Hanning window to minimize end effects. Oscillation frequencies
were in the lower gamma frequency range (close to 25--30 Hz), typical
of in vitro gamma models in submerged-style recording chambers
(Mann et al. 2005; Oren et al. 2006; Fisahn et al. 2009; Hajos et al. 2009;
Gulyas et al. 2010; Mann and Mody 2010). Hence, oscillatory power was
sampled as the area under the PSD curve between 10 and 40 Hz. For
analysis of the phase coupling of cell ﬁring to the ongoing ﬁeld
potential oscillation, the ﬁeld recording was transformed by Morlet
wavelet and analyzed using circular statistics and Rayleigh probability.
For full details of gamma oscillation detection and cellular recordings,
see Supplementary Materials.
Results
NRG1
tg-type I Mice Become Relatively Hyperactive and
Develop a Spatial Working Memory Deﬁcit with Age
Spontaneous locomotor activity monitoring showed an age-
emergent hyperactivity in the NRG1
tg-type I mice (age-by-
genotype interaction, F3,108 = 3.68, P = 0.034; Fig. 1A and
Supplementary Fig. 2), with a signiﬁcant difference between
genotypes emerging at 12 months of age, when NRG1
tg-type I
mice were relatively hyperactive (F1,36 = 9.09, P = 0.005), as
a result of a decline in activity in the wt mice at this time point.
At 5 months, NRG1
tg-type I mice actually displayed a mild and
transient locomotor hypoactivity when placed into the activity
cages (see Supplementary Material and Supplementary Fig. 2),
consistent with our previous observation in animals of similar
age (Deakin et al. 2009). Perhaps related to the later
hyperactivity, body mass showed an age-by-genotype interac-
tion (F3,108 = 42.01, P < 0.001), with NRG1
tg-type I mice being
lighter at all time points beyond 5 months (all F1,36 > 28, P <
0.001; Supplementary Fig. 3).
Working memory was assessed with a discrete trial, spatial
nonmatching-to-place (rewarded alternation) task on a T-maze
(Fig. 1B). At 3--4 months, wt and NRG1
tg-type I mice had similar
rates of alternation (F1,38 = 0.36, P = 0.551), but at 10 months,
NRG1
tg-type I mice displayed a lower rate (F1,38 = 6.39, P = 0.016;
age-by-genotype interaction F1,38 = 5.27, P = 0.027).
Having demonstrated this age-emergent impairment, 2
further tests were performed. First, spatial short-term memory
in the older mice was assessed in a single-trial, spatial novelty
preference task, which relies on the animal’s exploratory drive
(Sanderson et al. 2007, 2008). Whereas wt mice spent more
time in the novel arm of a Y-maze compared with recently
visited, familiar arms and entered the novel arm more often,
this novelty preference was reduced in NRG1
tg-type I mice,
conﬁrming the presence of impaired spatial short-term
memory (Fig. 1C and Supplementary Table 2). Second, spatial
reference memory was tested in an appetitive Y-maze task and
Cerebral Cortex July 2012, V 22 N 7 1521was unimpaired in NRG1
tg-type I mice aged 11 months (Fig. 1D).
Hence, the NRG1
tg-type I mice have an age-emergent deﬁcit,
speciﬁcally in working/short-term memory, with intact asso-
ciative reference memory. There were no sex-by-genotype
interactions for any behavioral measure (not shown).
NRG1
tg-type I Mice Have Normal Basal Synaptic
Transmission and Hippocampal LTP
WenextexaminedwhetherNRG1typeIoverexpressionaffected
hippocampal circuit functioning. We found no difference in basal
synaptic transmission from CA3 to CA1 in young (Fig. 2A)o ro l d
(Fig. 2B)N R G 1
tg-type I mice. Increasing stimulation strength
increased fEPSP slope response in CA1 (F10,300 = 181.84, P <
0.001),buttherewasnointeractionwithgenotype,age,orsex(all
F10,300 <1.5,P > 0.2),normaineffectsofgenotypeorage(allF1,30
< 1.1, P > 0.3). PPF was recorded as a measure of presynaptic
plasticity and did not differ between genotypes (F1,32 = 0.27, P =
0.608), nor were there other main effects or interactions (F1,32
< 2.8,P > 0.1;young wt = 1.36± 0.08; young NRG1
tg-type I = 1.43±
0.06; old wt = 1.18± 0.08; old NRG1
tg-type I = 1.25± 0.11).
LTP was induced with TBS, replicating the paradigm used in
NRG1
+/– mice (Bjarnadottir et al. 2007). LTP magnitude was not
affected in NRG1
tg-type I mice at either age, nor were there
interactions between genotype, age, or sex (all F1,41 < 1.7, P >
0.2; Fig. 2C,D).
NRG1
tg-type I Mice Show Altered Hippocampal Gamma
Oscillatory Frequency and a Lower Threshold to
Carbachol-Induced Epileptiform Activity
With LTP unaffected, we focused on oscillatory network
activity in the gamma frequency range, which may be
a correlate of memory encoding and retrieval (Engel et al.
2001; Montgomery and Buzsaki 2007; Herrmann et al. 2010;
van Vugt et al. 2010). Robust gamma frequency oscillations
were induced in CA3 by cholinergic activation (5--20 lM
carbachol; Fig. 3A1). Oscillations in slices from wt mice
(n = 19 slices from 9 mice) showed a mean frequency of 26.3
± 1.1 Hz, in line with previous reports using these conditions
( s e eM a t e r i a l sa n dM e t h o d s ) .S l i c e sf r o mN R G 1
tg-type I mice
also presented stable oscillations (Fig. 3A2, Supplementary
Fig. 4) but of lower peak frequency (22.0 ± 0.9 Hz; P = 0.005)
(Fig. 3B1). Oscillatory power did not differ between geno-
types (Fig. 3B2; P = 0.29).
To probe action potential ﬁring of individual pyramidal
neurons during gamma oscillations, we performed loose cell-
attached voltage clamp recordings from these cells (Fig. 3C1).
Neither the ﬁring rate (wt: 14 cells from 6 mice, NRG1 tg type
I: 12 cells from 7 mice; P = 0.36; Fig. 3C2) nor the strength of
coupling of the ﬁring to the oscillation (P = 0.38; Fig. 3C3)
differed between genotypes. In both groups, signiﬁcantly
coupled CA3 pyramidal cells (Rayleigh P < 0.05, wt: 12 cells
from 5 mice, NRG1
tg-type I: 12 cells from 7 mice) showed phase-
coupling characteristic of gamma oscillations and ﬁred
preferentially at the start of the cycle, near the minimum of
the ﬁeld oscillation cycle (Fig. 3C4).
In addition to slower gamma oscillations, slices from
NRG1
tg-type I mice were more prone to develop epileptiform
activity. Epileptiform discharges, detected by recordings in
CA3, consisted of short interictal-like bursts and/or longer
duration (>1 s) ictal-type episodes and occurred following
wash-in of carbachol, but not at baseline (Fig. 4A). Over 60% of
Figure 1. Behavioral phenotypes in NRG1
tg-type I mice: age-emergent locomotor
hyperactivity and deﬁcit in spatial short-term memory but not reference memory.
(A) Spontaneous locomotor activity (total beam breaks in a 2-h session). NRG1
tg-type I
mice (triangles; male n 5 9, female n 5 8) were hyperactive at 12.5 months
compared with wt mice (ﬁlled squares; male n 5 10, female n 5 13; P 5 0.005).
See also Supplementary Materials and Supplementary Figure 2. (B) Spatial working
memory: rewarded alternation in the T-maze showing percent correct alternations
from 50 trials. At 3--4 months (3 m), NRG1
tg-type I mice (gray) did not differ from wt
littermates (black), but at 10 months (10 m), NRG1
tg-type I mice made fewer correct
alternations than wt (P 5 0.016). At both time points, wt male n 5 10, female n 5 14;
NRG1
tg-type I male n 5 9, female n 5 9. (C) Single-trial, spatial novelty preference Y-maze
task in 10- to 11-month-old NRG1
tg-type I (gray; n 5 10) and wt (black; n 5 16) mice.
(C1) Time spent in novel arm minus time spent in the other arm. NRG1
tg-type I mice spent
relatively less time in the novel arm than wt (F1,22 5 4.21, P 5 0.05). (C2)N u m b e ro f
entries into novel arm minus number of entries into other arms. NRG1
tg-type I mice made
relatively fewer entries into the novel arm than wt (F1,22 5 4.85, P\0.05). For raw data,
see Supplementary Table 2. (D) Spatial reference memory acquisition in an
appetitive Y-maze task showing normal performance in 11-month-old NRG1
tg-type I
mice (triangles, n 5 10) compared with wt littermates (ﬁlled squares, n 5 12); main
effect of genotype, F1,20\1; genotype by block, F7,140\1. Data shown as mean ±
standard error of the mean.
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tg-type I slices (22 of 36 slices, from 7 of 11 mice) showed
carbachol-induced epileptiform activity, compared with only
9% of wt slices (2 of 22 slices, from 2 of 9 mice) (Fisher’s exact
test, P < 0.0001; Fig. 4B).
Discussion
NRG1 exists as multiple isoforms, which differ in their CNS
expression and their signaling and processing characteristics
(Falls 2003; Corfas et al. 2004; Mei and Xiong 2008). Un-
derstanding this complexity is important since the isoforms
exhibit functional differences (Flames et al. 2004; Michailov
et al. 2004; Taveggia et al. 2005; Brinkmann et al. 2008; Chen
et al. 2008) and may contribute differentially to schizophrenia
(Harrison and Law 2006; Chen et al. 2009), wherein type I
NRG1 is increased (Hashimoto et al. 2004; Law et al. 2006).
However, virtually nothing is known about this isoform in the
brain. Here we studied NRG1 type I overexpressing mice and
found a selective and age-emergent impairment of working
memory, a reduced frequency of hippocampal gamma oscil-
lations and increased epileptiform activity, but normal LTP. The
results reveal roles of the type I isoform of NRG1 in
hippocampal function and may have implications for the
involvement of NRG1 type I in schizophrenia.
Age-Emergent Spatial Working Memory Deﬁcits in NRG1
tg-
type I Mice
NRG1
tg-type I mice were impaired on rewarded alternation,
a spatial working memory task, at ~10 months, a ﬁnding
corroborated with a single-trial task and contrasting with their
preserved spatial reference memory. The latter implies that
nonspeciﬁc confounds (e.g., sensorimotor function or motiva-
tion) are unlikely to be responsible for the working/short-term
memory deﬁcit. These are to our knowledge the ﬁrst data
showing that NRG1 impacts upon hippocampus-dependent
cognition, complementing the limited evidence for attentional
or memory impairments in NRG1 hypomorphic mice (Chen
et al. 2008; Duffy et al. 2010). Notably, young NRG1
tg-type I mice
performed entirely normally on the same spatial working
memory task, indicating that the deﬁcit emerges between 4 and
10 months of age, a time period later than that classically
associated with NRG1 functions but consistent with the
increasing focus upon roles of NRG1 in adulthood.
Although it is parsimonious to interpret the selective
memory deﬁcits as being directly related to the hippocampal
overexpression of NRG1 type I, the mice also overexpress
the gene in some other regions (Deakin et al. 2009;
Supplementary Fig. 1). The behavioral phenotype clearly
extends beyond the hippocampal domain, as evidenced by
o u re a r l i e rs t u d y( D e a k i ne ta l .2 0 0 9 ) ,a n dt h eh i p p o c a m p u si s
not the only brain area that is important for performance on
the spatial memory tasks used in the present paper.
Nevertheless, the hippocampus is one brain area that is essential
for spatial short-term memory (e.g., Deacon et al. 2002;
Sanderson et al. 2007), and performance is likely to involve
extended neural circuits, which include the hippocampus as one
component.
Kato et al. (2010) recently described a separate line of
NRG1
tg-type I mice, in which the transgene was tagged to green
ﬂuorescent protein and driven by an elongation factor 1a
promoter. They reported decreased social interactions and
impaired contextual fear learning, as well as increased
locomotor activity, and reductions in hippocampal dopaminer-
gic markers. Extrapolation to the present ﬁndings is limited
because Kato et al. (2010) did not use comparable cognitive
tests and only examined young (8- to 12-week old) animals.
Direct comparison of the lines would be of interest; some
phenotypic differences might well be anticipated given the
differing constructs and the magnitude and distribution of
overexpression.
Figure 2. Normal basal synaptic transmission and LTP in NRG1
tg-type I mice. (A and C) Young mice (2.5--5 months old); (B and D) old mice (10--13 months old). Data are mean
and standard error of the mean with example traces. Wt: black squares and black traces; NRG1
tg-type I: open triangles and gray traces. (A and B) Stimulus response curves (A: wt,
n 5 8; NRG1
tg-type I, n 5 11; B: wt, n 5 12, NRG1
tg-type I, n 5 11). Scale bars: 1 mV and 5 ms. (C and D) LTP (E: wt, n 5 11; NRG1
tg-type I, n 5 12; F: wt, n 5 12, NRG1
tg-type I,
n 5 12). Scale bars: 5 mV and 5 ms. There are no differences between genotypes at either age.
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tg-type I mice. (A). Cholinergic activation by carbachol (CCh) induces gamma frequency oscillations in hippocampal
slices from wt and NRG1
tg-type I mice. One-second-long sample traces (low-pass ﬁltered at 200 Hz) of the recorded ﬁeld potential oscillations in the hippocampal CA3 pyramidal
cell layer and corresponding PSDs in a wt mouse (A1) and a NRG1
tg-type I mouse (A2). PSDs, computed for the entire 60-s-long traces, conﬁrm lower peak frequency in the
NRG1
tg-type I mice. (B) Summary box plots of all recordings demonstrate that peak frequencies (shown in B1) were consistently lower in NRG1
tg-type I slices (mean peak frequency
in wt: 26.2 ± 1.0 Hz [mean + standard error of the mean] vs. NRG1
tg-type I: 22.0 ± 0.9 Hz; P 5 0.006**). Whiskers indicate 90th and 10th percentiles of the data; outlying
points are also plotted, dotted lines represent the mean. (B2) Mean oscillatory power did not differ between groups (wt: 107.0 ± 44.8 lV
2/Hz vs. NRG1
tg-type I: 141.4 ± 41.3
lV
2/Hz; P 5 0.44). (C) CA3 pyramidal cell ﬁring during gamma oscillations. (C1) Representative extracellular ﬁeld and corresponding cell-attached recordings from slices taken
from wt (top) and NRG1
tg-type I (bottom) mice. (C2) Histogram comparing the mean ﬁring rate (Hertz) of individual pyramidal cells in wt (black) and NRG1
tg-type I (gray) mice, with
scatter plots corresponding to their ﬁring rates. Statistical analysis revealed no difference between the groups (wt: 2.70 ± 0.56, NRG1
tg-type I: 3.66 ± 0.81; P 5 0.36). (C3)
Histogram comparing the strength of pyramidal cell ﬁring coupling to the ﬁeld oscillation in wt (black) and NRG1
tg-type I (gray) mice, plus scatter plots representing the coupling
values of all individual cells recorded. The average vector length (see Supplementary Materials) did not differ between genotypes (wt: 0.38 ± 0.03; NRG1
tg-type I mice: 0.43 ±
0.05; P 5 0.38). Error bars in C2 and C3 are standard error of the mean. (C4) Distributions of the mean angles (degrees) at which cells ﬁred relative to the ﬁeld potential oscillation
(wt: 12 cells from 5 mice; NRG1
tg-type I: 12 cells from 7 mice). A representative cycle-averaged ﬁeld oscillation is shown to illustrate phase deﬁnition. Firing of pyramidal cells is
similarly phase locked to ascending phase of a ﬁeld gamma cycle in both genotypes with no difference between groups (wt [black]: 111.4  ± 10.0 , NRG1
tg-type I [gray]:
93.3  ± 9.2 ; P 5 0.106).
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Gamma Oscillations
Several studies have shown that hippocampal LTP is affected by
genetic or pharmacological manipulation of NRG1. Acute
administration of NRG1 peptide acutely suppresses (Huang
et al. 2000; Pitcher et al. 2008; Chen et al. 2010) or reverses
(Kwon et al. 2005, 2008) LTP, and LTP is decreased in NRG1
hypomorphs (Huang et al. 2000; Bjarnadottir et al. 2007). These
results suggest an ‘‘inverted U’’ relationship between NRG1
signaling and LTP (Role and Talmage 2007) as well as between
NRG1 ‘‘dose’’ and some other parameters (Li et al. 2007; Syed
et al. 2010). Given these ﬁndings and the age-emergent working
memory deﬁcit, we anticipated an impairment of LTP in the old
but perhaps not the young NRG1
tg-type I mice, but in fact, LTP
was normal at both ages. This may reﬂect the differing
consequences of constitutive overexpression of NRG1 com-
paredwiththeacuteeffectsofexogenousNRG1.Italsosuggests
that the type I isoform is not involved in NRG1 modulation of
CA1LTPand,bydefault,implicatestypeIIorIIINRG1,whichare
also expressed in the hippocampus (Law et al. 2006; Woo et al.
2007). Combining genetic and pharmacological manipulations
of NRG1 will help clarify these issues.
Hippocampal gamma oscillations are generated by parvalbu-
minergic (PV+) interneurons (Mann et al. 2005; Bartos et al.
2007; Mann and Paulsen 2007; Gulyas et al. 2010). These are the
primary ErbB4-expressing cell population (Krivosheya et al.
2008; Vullhorst et al. 2009; Fazzari et al. 2010), and NRG1--
ErbB4 signaling regulates their synaptic development (Fazzari
et al. 2010) and their release of c-aminobutyric acid (GABA)
(Woo et al. 2007; Wen et al. 2010). The frequency of
hippocampal gamma oscillations is regulated by activation of
interneuronal N-methyl-D-aspartate (NMDA) receptors (Mann
and Mody 2010) and is inﬂuenced by genetic factors and
correlated with GABAA receptor subunit expression (Heistek
et al. 2010). Moreover, gamma oscillatory frequency in vivo is
positively correlated with local GABA concentration, at least in
human visual cortex (Muthukumaraswamy et al. 2009). These
ﬁndings together strongly implicate PV+ interneurons, driven
by enhanced or otherwise aberrant NRG1--ErbB4 signaling, as
the basis for the alterations in gamma oscillatory frequency
seen in the NRG1
tg-type I mice. However, NRG1 acting via ErbB4
receptors stimulates interneuronal GABA release (Woo et al.
2007), and NRG1 overexpression might be expected to elevate
this and so in turn be associated with an increased (not
decreased) gamma frequency. It is also relevant that hippo-
campal gamma oscillations are altered by NRG1 peptides, but
the effect is on power not frequency and occurs in response to
kainate not carbachol (Fisahn et al. 2009). As with the LTP
result, these ﬁndings together suggest a particular role of the
type I isoform in the modulation of gamma oscillations; they
also highlight that the duration and magnitude of NRG1
elevation are likely important determinants of its functional
effects. As a ﬁrst step toward characterization of PV+ cells in
NRG1
tg-type I mice, we have found no gross differences in
hippocampal PV+ cell density in the mice (Supplementary
Table 3 and Supplementary Fig. 5), but considerable further
investigations are required to establish the functional status of
these interneurons and to clarify the range of oscillatory
responses to NRG1 isoforms in different circuits and experi-
mental paradigms.
Figure 4. Hippocampal slices from NRG1
tg-type I mice are prone to carbachol-induced epileptiform activity. (A) Sample ﬁeld potentials during baseline (top trace) and following
application of 20 lM carbachol (CCh; middle and bottom traces) in slices from NRG1
tg-type I mice. The lower 2 panels show examples of carbachol-evoked epileptiform ﬁeld
potential discharges resembling ictal and interictal-like bursts. (B) Pie charts illustrate the percentage of slices in which cholinergic activation (5--20 lM carbachol) results in
robust gamma oscillations (empty segment) or immediate ﬁeld epileptiform activity (ﬁlled segment). The proportion showing epileptiform activity is higher in slices from
NRG1
tg-type I mice than wt mice (Fisher’s exact test, P \ 0.0001).
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oscillations likely indicates a disturbed timing and suboptimal
efﬁciency of hippocampal circuits and thereby an impairment
of gamma-related hippocampal functions. It is of interest that
a similar phenotype to that of NRG1
tg-type I mice—that is,
altered gamma oscillations, deﬁcient spatial working memory,
and intact reference memory—is seen in mice with conditional
ablation in PV+ interneurons of GluA1 (Fuchs et al. 2007) or
GluN1 (Korotkova et al. 2010) glutamate receptors. Impaired
working memory is also seen in PV+ ErbB4 knockout mice
(Wen et al. 2010). Notably, it has also recently been shown that
functional removal of CA1 PV+ interneurons produces a selec-
tive impairment in spatial working memory but spared spatial
reference memory (Murray et al. 2011), reminiscent of the
pattern of effects observed here. These ﬁndings draw further
attention to the hippocampal PV+ cell population as a contrib-
utor to the behavioral and electrophysiological phenotype of
the NRG1
tg-type I mice, albeit their working memory deﬁcit did
not arise until 10 months of age despite the oscillatory change
already being present in younger mice. This temporal
dissociation indicates either that the 2 aspects of phenotype
are not in fact related or that the emergence of memory
impairment in the NRG1
tg-type I mice requires additional factors
beyond the oscillopathy.
During hippocampal gamma oscillations, oxygen consump-
tion is comparable to that of seizure-like events (Kann et al.
2011) and gamma activity is sensitive to hypoxia (Huchzermeyer
et al. 2008). Fast-spiking interneurons are especially sensitive,
with respiratory chain inhibition producing a markedly reduced
frequency of inhibitory postsynaptic potentials, as well as
decreased gamma power (Whittaker et al. 2011). The fact that
hippocampal slices from NRG1
tg-type I mice were predisposed to
epileptiform activity, as well as exhibiting decreased gamma
oscillatory frequency, may indicate that their mitochondrial
function is impaired or that they have greater gamma-related
metabolic demands than wt mice.
Implications for NRG1 in Schizophrenia
NRG1
tg-type I mice are, to our knowledge, the ﬁrst genetic
mouse model of schizophrenia that also reproduces an isoform-
selective change in expression of the gene that occurs in the
disorder. It is thus of interest to consider the extent to which
their phenotype recapitulates elements of schizophrenia.
Several features stand out in this regard. First, the focus upon
PV+ interneurons is congruent with contemporary models,
which envisage a critical role for these cells and their NMDA
receptors in the pathogenesis of the disorder (e.g., Gonzalez-
Burgos and Lewis 2008; Lisman et al. 2008; Lodge et al. 2009;
Belforte et al. 2010; Woo et al. 2010). The present data suggest
that NRG1 type I may contribute to this dysfunction (Banerjee
et al. 2010; Buonanno 2010). At ﬁrst sight, other ﬁndings in the
NRG1
tg-type I mice also appear broadly in keeping with
schizophrenia, such as the spatial working memory impairment
(Piskulic et al. 2007; Forbes et al. 2009) and altered gamma
oscillatoryfrequency(Spenceretal.2004).However,thereisless
congruence when these ﬁndings are considered more critically.
Thus, in schizophrenia, memory impairment is present at, or
before, the ﬁrst episode (i.e., by early adulthood; Mesholam-
GatelyandGiuliano2009),whereasitonlyemergedhereinolder
mice.Inanyevent,itisunclearwhetherspatialworkingmemory
as conceptualized and studied in humans is directly comparable
to the term when applied to rodents (Sanderson and Bannerman
2011). And, apart from Spencer et al. (2004), most studies in
schizophrenia have reported differences in gamma power not
frequency, and all concern neocortical oscillations (Uhlhaas and
Singer 2010). Moreover, preliminary data in NRG1
tg-type I mice
indicate hippocampal enlargement (I.H.D. and P.J.H., unpub-
lished observations), whereas in schizophrenia, hippocampal
volumeisdecreased(Harrison2004).Thus,theresultsoveralldo
not support the interpretation that NRG1
tg-type I mice show
a schizophrenia-like phenotype.
These considerations highlight the conceptual and interpre-
tational limitations of genetic mouse models of psychiatric
disorders (Desbonnet et al. 2009; Kellendonk et al. 2009;
Arguello and Gogos 2010; Harrison et al. 2011) and show they
apply even when, as here, the genetic manipulation reproduces
an isoform-selective alteration in expression of a strong
candidate gene and therefore has a relatively high construct
validity (Nestler and Hyman 2010). Several factors, other than
simply the complex genetic and environmental risk architec-
ture of the disorder, may contribute to the ‘‘non--schizophrenia-
like’’ aspects of the NRG1
tg-type I phenotype. For example, the
greater magnitude of overexpression compared with that
observed in schizophrenia. And, since it is not known when
the overexpression of type I NRG1 (or its pathogenic effects)
begins in people who develop schizophrenia, we do not know
whether the early onset and persistent overexpression in the
mice is a good approximation to the disease state.
In summary, these data show that NRG1 type I impacts upon
hippocampal function and circuitry. The ﬁndings also illustrate
the manifold and partly isoform speciﬁc, contributions which
NRG1 makes to the development and plasticity of the CNS, as
well as potentially to its pathophysiology.
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